Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study.
Saved in:
| Title: | Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study. |
|---|---|
| Authors: | Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Min JS; Evidation Health, San Mateo, CA, USA., Lee WN; Evidation Health, San Mateo, CA, USA., Yu JC; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Patel Y; Alexion, AstraZeneca Rare Disease, Boston, MA, USA., Myren KJ; Health Economics and Outcome Research, Alexion Pharmaceuticals, Inc., Stockholm, Sweden., Dingli D; Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Dingli.David@mayo.edu. |
| Source: | Health and quality of life outcomes [Health Qual Life Outcomes] 2024 Aug 09; Vol. 22 (1), pp. 62. Date of Electronic Publication: 2024 Aug 09. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101153626 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7525 (Electronic) Linking ISSN: 14777525 NLM ISO Abbreviation: Health Qual Life Outcomes Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-7525 |
|---|---|
| DOI: | 10.1186/s12955-024-02279-2 |
